Literature DB >> 18677864

[Characteristics and effectiveness of smoking cessation programs in Italy. Results of a multicentric longitudinal study].

Valeria Belleudi1, Anna Maria Bargagli, Marina Davoli, Alessandra Di Pucchio, Roberta Pacifici, Enrica Pizzi, Piergiorgio Zuccaro, Carlo Alberto Perucci.   

Abstract

AIM: to describe the characteristics and effectiveness of various smoking cessation programs offered by Italian treatment services operating within the National Health Service.
DESIGN: prospective longitudinal multicentre study involving 41 smoking cessation services in 16 Italian regions. STUDY POPULATION: the study population includes patients entering smoking cessation programs between April 2003 and June 2004. The "study population" includes 1226 patients (54.2% males and 45.4% females), mean age 47 years. Patients have a middle/high level of education and a long history of smoking; most are highly dependent on nicotine and report previous attempts to quit smoking.
METHODS: treatment effectiveness in smoking cessation is assessed six months after entering treatment service. Logistic Regression Model was used to determine the predictors of successfiul cessation, independent of treatment typology. The predictors were included as confounding variables in the logistic regression model that was used to evaluate the effectiveness of treatments. Besides the effect of treatment completion on smoking cessation was estimated.
RESULTS: predictors of successful smoking cessation are: being male, presence of a partner, strong motivation to quit, previous attempts to give up smoking, mild nicotine dependence, and not suffering from mood disturbances. All treatments are effective in helping people to stop smoking: cessation rate ranges between 25.00% for patients receiving a single session of motivational counselling and 65.3% for those receiving nicotine replacement therapy combined to group therapy. Compared to a single session of motivational counseling, nicotine replacement therapy combined to group therapy is the most effective therapeutic program (OR 5.4; 95%CI 12.5-12.0). Treatment completion is a strong determinant ofsuccess (OR 4.8; 95%CI 3.5-6.4).
CONCLUSION: enrolling people in any type of therapeutic program, in particular nicotine replacement therapy combined with group therapy increases the probability of successfully quitting smoking; moreover, patients that begin a smoking cessation program should be encouraged to complete the therapy

Entities:  

Mesh:

Year:  2007        PMID: 18677864

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  5 in total

Review 1.  Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.

Authors:  Michael Mamoun; Andrew W Bergen; Jennifer Shieh; Anna Wiggins; Arthur L Brody
Journal:  CNS Drugs       Date:  2015-05       Impact factor: 5.749

2.  Epidemiologic determinants affecting cigarette smoking cessation: a retrospective study in a National Health System (SSN) treatment service in Rome (Italy).

Authors:  Maria Giulia Marino; Elisabetta Fusconi; Rosanna Magnatta; Augusto Panà; Massimo Maurici
Journal:  J Environ Public Health       Date:  2010-04-13

3.  A helpline telephone service for tobacco related issues: the Italian experience.

Authors:  Enrica Pizzi; Alessandra Di Pucchio; Luisa Mastrobattista; Renata Solimini; Roberta Pacifici; Simona Pichini
Journal:  Int J Environ Res Public Health       Date:  2009-02-26       Impact factor: 3.390

4.  National survey of the smoking cessation services in Italy.

Authors:  Alessandra Di Pucchio; Enrica Pizzi; Giordano Carosi; Monica Mazzola; Donatella Mattioli; Roberta Pacifici; Simona Pichini
Journal:  Int J Environ Res Public Health       Date:  2009-02-26       Impact factor: 3.390

5.  Impact of Referral Sources and Waiting Times on the Failure to Quit Smoking: One-Year Follow-Up of an Italian Cohort Admitted to a Smoking Cessation Service.

Authors:  Lucia Borsari; Simone Storani; Carlotta Malagoli; Tommaso Filippini; Marco Tamelli; Marcella Malavolti; Fausto Nicolini; Marco Vinceti
Journal:  Int J Environ Res Public Health       Date:  2018-06-11       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.